Detalhe da pesquisa
1.
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 16-Week Trial to Evaluate the Efficacy and Safety of FB-401 in Children, Adolescents, and Adult Subjects (Ages 2 Years and Older) with Mild-to-Moderate Atopic Dermatitis.
Dermatology
; 240(1): 85-94, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37579728
2.
Integrated Exposure-Response of Dupilumab in Children, Adolescents, and Adults With Atopic Dermatitis Using Categorical and Continuous Efficacy Assessments: A Population Analysis.
Pharm Res
; 40(11): 2653-2666, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38082089
3.
Safety, pharmacokinetics, and efficacy of ruxolitinib cream in children and adolescents with atopic dermatitis.
Ann Allergy Asthma Immunol
; 130(4): 500-507.e3, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36586583
4.
Transition readiness in adolescents and young adults with chronic genetic skin conditions.
Pediatr Dermatol
; 40(4): 621-626, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37081816
5.
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials.
Lancet
; 397(10290): 2151-2168, 2021 06 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34023008
6.
Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis-A pooled analysis of trial data.
Pediatr Dermatol
; 39(2): 187-196, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35083774
7.
Efficacy and patient-reported outcomes from a phase 2b, randomized clinical trial of tapinarof cream for the treatment of adolescents and adults with atopic dermatitis.
J Am Acad Dermatol
; 84(3): 632-638, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32502588
8.
Consensus recommendations for the use of retinoids in ichthyosis and other disorders of cornification in children and adolescents.
Pediatr Dermatol
; 38(1): 164-180, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33169909
9.
Improvement in disease severity and pruritus outcomes with crisaborole ointment, 2%, by baseline atopic dermatitis severity in children and adolescents with mild-to-moderate atopic dermatitis.
Pediatr Dermatol
; 37(6): 1030-1037, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32981097
10.
Sodium hypochlorite body wash in the management of Staphylococcus aureus-colonized moderate-to-severe atopic dermatitis in infants, children, and adolescents.
Pediatr Dermatol
; 36(4): 442-447, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30983053
11.
Prevalence of Psoriasis in Children and Adolescents in the United States: A Claims-Based Analysis.
J Drugs Dermatol
; 17(2): 187-194, 2018 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29462227
12.
Oncofertility considerations in adolescents and young adults given a diagnosis of melanoma: Fertility risk of Food and Drug Administration-approved systemic therapies.
J Am Acad Dermatol
; 75(3): 528-534, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27543212
13.
Long-term safety and efficacy of etanercept in children and adolescents with plaque psoriasis.
J Am Acad Dermatol
; 74(2): 280-7.e1-3, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26775775
14.
Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: results of the randomized phase 3 CADMUS study.
J Am Acad Dermatol
; 73(4): 594-603, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26259989
15.
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2).
Am J Clin Dermatol
; 25(3): 485-496, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38528257
16.
Safety and Efficacy of Lebrikizumab in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis: A 52-Week, Open-Label, Phase 3 Study.
Dermatol Ther (Heidelb)
; 13(7): 1517-1534, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37318750
17.
Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis: The Phase 3 ECZTRA 6 Randomized Clinical Trial.
JAMA Dermatol
; 159(6): 596-605, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37074705
18.
Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis: Analysis of the Measure Up 1, Measure Up 2, and AD Up Randomized Clinical Trials.
JAMA Dermatol
; 159(5): 526-535, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37043227
19.
Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE).
Am J Clin Dermatol
; 23(3): 365-383, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35567671
20.
Etanercept treatment for children and adolescents with plaque psoriasis.
N Engl J Med
; 358(3): 241-51, 2008 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-18199863